Latin America Healthcare Analytics Market valued at USD 0.71 Billion in 2019 and is expected to reach USD 1.71 Billion by the end of 2024 with a CAGR of 19.12% during the forecast period 2019-2024.
Healthcare analytics is the analysis of data collected through various sources to designate the trends and patterns that help to effectively improvise healthcare.
Fuelling of the growth in analytics is enabled through the advancements of IT in healthcare segment over the past many year. Through the analysis of the chronological data, future trends can be predicted along with evaluating decisions and measuring the business performance that helps in improving the outcomes. This advancements also helps in improving accuracy, service delivery and efficiency of the healthcare system with better clinical outcome laterally reducing the healthcare cost and readmissions.
The concerns regarding the security issues, breaching of confidential information, cultural and technological barriers, and lack of skilled workforce may hinder the growth of the healthcare analytics industry around the globe. And also, barriers associated with creating a network for analytics as a result of weekend international political and economic relations may also turn out to be a major threat towards the growth of the market.
Amongst end users, the healthcare providers segment is a vital market among the end-users as it is expected to grow at the higher CAGR during the predicted period. As a result of mandatory federal regulations, there were the implementation of ICD-10 code sets and EHRs, swing towards value-based medicine, and the increased focus on quality care and reduced costs are propelling the growth of this segment.
Latin America Healthcare Analytics Market segmented and sub-segmented into the following categories:
Latin America accounts to only about XX% of the global healthcare analytics market in 2018 but is predicted to witness a comparatively low growth rate in the forecast period.
Major companies dominating the Latin America Healthcare Analytics Market are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Predictive Analytics
5.1.2 Descriptive/Restrospective Analytics
5.1.3 Prescreptive Analytics
5.2 By Application
5.2.1 Financial Analytics
5.2.2 Clinical Analytics
5.2.3 Operational & Administrative Analytics
5.3 By End-user
5.3.1 Public Health Systems
5.3.2 Healthcare Providers
5.3.3 Private Healthcare Providers
5.3.4 Monitoring Agencies
5.3.5 Health Insurance Companies
5.3.6 Clinical and Medical Research Bodies
5.3.7 Technology Vendors
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 McKesson
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 SAS Institute Inc
8.3 Optum Inc.
8.4 IBM Corporation
8.5 Truven Health Analytics Inc.
8.6 Cerner Corporation
8.7 Verisk Analytics Inc.
8.8 Allscripts Health Solutions
8.9 Oracle Corporation
8.10 MedeAnalytics Inovalon Inc.
8.11 Health Catalyst
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
